2021, Number 1
<< Back Next >>
Aten Fam 2021; 28 (1)
Cognitive Impairment in Elderly with Type 2 Diabetes Mellitus
Zavala RJD, Compean OLG, Leal UE, Meza EJP
Language: Spanish
References: 22
Page: 43-48
PDF size: 198.23 Kb.
ABSTRACT
Objective: to compare the prevalence
of cognitive impairment in elderly
with and without type 2 diabetes
mellitus in a Primary Care level unit.
Methods: cross-sectional study carried
out in Ciudad Mante, Tamaulipas,
Mexico. Simple randomized sampling
was used; the sample calculation was
performed for finite populations with
a 95% confidence level, 153 patients
were evaluated. Older adults with and
without DM2, without a diagnosis of
cognitive impairment, dementia or
depression were taken as inclusion
criteria. It was applied the modified
version of the Mini-Mental State Examination
(MMSE) validated in Mexican
population, descriptive and inferential
statistics analysis were made through
χ
2Results: 153
patients were evaluated, the average age
was 69.76 years (±6.82), and women
predominated with 91 participants
(60%). All patients were divided in two
groups, the first one was based on the
diagnosis of DM2 with 80 participants
(52.3%) and the second one, without
this disease with 73 (47.7%); globally,
48 patients were at risk of cognitive
impairment, patients with DM2, it was
13.72% (n=21), while patients without
DM2, it was 17.64% (n=27). There
were no statistically significant differences
in any of the groups (p›0.05).
Conclusion: no statistically significant
differences were found to support a predominance
of cognitive impairment in
patients with DM2, an aspect considered
in other studies; other clinical characteristics
and the life course of each patient
should be studied in depth in order to
establish possible associations among
the study variables.
REFERENCES
García B, Jiménez B. Envejecimiento y urbanización: implicaciones de dos procesos coincidentes. Investigaciones Geograficas, Instituto de Geografía UNAM. 2016;(89):58-73.
Instituto Nacional de Estadística Geografía. Estadísticas a propósito del dia internacional de las personas de edad, INEGI. Aguascalientes, 2016.
Secretaría de Salud. Promover el envejecimiento activo, saludable, con dignidad y la mejora de la calidad de vida de las personas adultas mayores. Estrategia 1.7, Tercer informe de labores 2014- 2015, Mexico 2015.
Nishtar S. La diabetes: un grave problema de salud femenina. Diabetes Voice. 2017;63(3):4-5.
International Diabetes Federation (IDF), Diabetes Atlas. USA. 2015.
Resultados ENSANUT 2018 [Internet]. [Citado 2020 Sept 25]. Disponible en: https://ensanut. insp.mx/encuestas/ensanut2018/doctos/informes/ ensanut_2018_presentacion_resultados.pdf
Zenteno MA. et al. Función cognitiva en el adulto mayor con y sin diabetes tipo 2. Revista Científica de la Sociedad Española de Enfermería Neurológica. 2016;44:3-8.
Morrison J, Baxter M. The ageing cortical synapse: hallmarks and implications for cognitive decline. Neuroscience. 2012;13(2):240-250
Gregorio P. Criterios diagnósticos. beneficios del diagnóstico precoz. Rev Esp Geriatr Gerontol. 2016;51(S1):7-11.
Rodríguez J. Definición y prevalencia del deterioro cognitivo leve. Revista española de Geriatría y gerontología. 2017;52(S1):3-8.
Ciudin A, Simó-Servat O, Valladares S, Ruiz A, Hernandez C, Boada M, et al. La diabetes mellitus tipo 2 es un factor de riesgo inependiente para la conversión a la demencia en pacientes con deterioro cognitivo leve. Complicaciones de la diabetes. Avances en diabetología. 2014;663(5):30-45
Formiga F, Perez M, diabetes mellitus tipo 3 ¿El renacer de la insulina inhalada?. Endocrinología. 2014;61(4):172-175.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition. 2013 [Internet]. [Citado 2020 Jun 7]. Disponible en: https://psychiatryonline.org/doi/ book/10.1176/appi.books.9780890425596
Freire A. Métodos de cribaje del deterioro cognitivo leve en atención primaria. Revista española de Geriatría y Gerontología. 2017;52(S1):15-19.
Sosa A, Albanese E, Stephan B, Dewey M, Acosta D, Ferri C, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med. 2012;9(2):e1001170.
Reyes S, Beaman P, García C, Villa M, Heres J, Córdova A, et al. Validation of a Modifiied Version of the Mini-Mental State Examination (MMSE) in Spanish. Neuropsychology and Cognition. 2014;11(1):1-11.
Torres-Castro S, Mena-Montes B, González-Ambrosio G, Zubieta-Zavala A, Torres-Carrillo NM, Acosta-Castillo GI, et al. Escalas de tamizaje cognitivo en habla hispana: una revisión crítica. Neurología. 2018;S021348531830094X.
Arjona RD, Esperón RI, Herrera GM, Albertos NE, Asociación de diabetes mellitus con riesgo cognitivo en adultos mayores. Estudio basado en población. Revista Médica del Instituto Mexicano del Seguro social. 2014;52(4):416-421.
Jurado MB, Santibáñez R, Palacios M, Moreno D, et al. Deterioro cognitivo en paicentes diabéticos de 55 a 65 años de edad. Reporte final de estudio observacional transversal en la ciudad de Guayaquil. Revista Ecuatoriana de Neurología. 2018;27(1):41-50.
Teixeira MM, Passos VMA, Barreto SM, Schmidt MI, Duncan BB, Beleigoli AMR, et al. Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil). Sci Rep. 2020;10(1):1596.
Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. 2018;8(1):16128.
de Azeredo Passos VM, Giatti L, Bensenor I, Tiemeier H, Ikram MA, de Figueiredo RC, Chor D, Schmidt MI, Barreto SM. Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). BMC Neurol. 2015;15:191.
Full text